ETON --3x FDA Decisions: July & October 2019 , May 2020 Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ETON --3x FDA Decisions: July & October 2019 , May 2020

ETON 18.20

-0.4%

Oct 30 3:59 PM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: BioHero	8/19/2019 2:21:30 PM
	of 16

Mega opportunity to add or for new entry , lots of news on the way ... ETON ( $99 M) 4 Drugs awaiting FDA approval/ first FDA decision on October 21 / 3 NDA submission in Q4 2019 (more infos below) / Low float and undiscovered Stock = Potential 10 Bagger Gem Potential Upcoming Business Milestones: ET-104 Clinical Results (Third Quarter 2019) ET-103 Clinical Results (Third Quarter 2019) ET-202 PDUFA Date (October 21, 2019) Potential ET-103 NDA Submission (Fourth Quarter 2019) Potential ET-104 NDA Submission (Fourth Quarter 2019) Potential DS-300 ANDA Submission (Fourth Quarter 2019) EM-100 Amendment Submission (Fourth Quarter 2019) ET-105 PDUFA Date (March 17, 2020) Potential EM-100 FDA Response (First Quarter 2020)

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next